News

CBS News got an up-close look at a pilot's training inside a 737 Max simulator amid a renewed focus on the U.S.' aging air ...
I-Mab, a clinical-stage biopharmaceutical company with U.S. offices in Gaithersburg, Tuesday was awarded an arbitration victory stemming from a $200 million dispute with Tracon Pharmaceuticals ...
CBS News got an up-close look at a pilot's training inside a 737 Max simulator amid a renewed focus on the U.S.' aging air traffic control system.
Then their radar screen went out as well. ... later confirmed that the loss of a vulnerable data line connecting a radar facility in New York with the Philadelphia TRACON was to blame.
SAN DIEGO, Oct. 31, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development ...
The second screen outage at Newark Airport comes after air traffic control radars briefly went down on April 29, causing workers to be “unable to see, hear, or talk to [planes]” for reportedly ...
A high-level overview of TRACON Pharmaceuticals, Inc. (TCON) stock. View (TCON) real-time stock price, chart, news, analysis, analyst reviews and more.
Tracon stock has a session volume of 783K shares traded, compared to the trailing 100-day volume of 194.7K shares. According to data from Benzinga Pro , TCON has a 52-week high of $2.31 and a 52 ...
Tracon Pharmaceuticals (TCON) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...